Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

Boston Scientific recalls Fetch 2 aspiration catheter

Boston Scientific voluntarily recalled all models of its Fetch 2 aspiration catheter after receiving complaints of shaft breakage during procedures to remove small blood clots from the coronary arteries.

Jury rules in favor of Abbott in whistleblower lawsuit

A Texas jury ruled that Abbott did not cause medical providers to submit false payment claims and billing codes to Medicare for unapproved stents, Bloomberg reports. 

FDA approves Impella heart pumps to treat ongoing cardiogenic shock

The FDA approved the Impella heart pumps on April 7 to treat patients with ongoing cardiogenic shock following acute MI or open heart surgery as a result of isolated left ventricular failure.

Thumbnail

Registry analysis provides real-world data on TAVR outcomes

Centers that have experienced operators and perform more TAVR procedures have significantly better risk-adjusted in-hospital mortality rates and risk-adjusted bleeding rates compared with less experienced centers.

ACC.16: TAVR outcomes improve with increasing volume of procedures

CHICAGO – An observational study of more than 40,000 transcatheter aortic valve replacement (TAVR) procedures found that outcomes have improved in recent years as hospitals and physicians perform more procedures.

ACC.16: TAVR with the Sapien XT valve is non-inferior to surgery at two years

CHICAGO – After two years, intermediate-risk patients with severe, symptomatic aortic stenosis who underwent transcatheter aortic valve replacement (TAVR) with the Sapien XT valve had similar rates of all-cause mortality or disabling stroke compared with those who underwent surgical aortic valve replacement.

Thumbnail

ACC.16: Strategies may help hospitals reduce readmissions following PCI

CHICAGO – A large mixed methods study identified several strategies that hospitals employed that were independently associated with lower risk-standardized 30-day readmission rates following PCI.

Most patients referred for catheterization before noncardiac surgery are asymptomatic

More than 60 percent of clinically stable patients undergoing cardiac catheterization and/or PCI before noncardiac surgery were asymptomatic, according to a retrospective, descriptive analysis of a large national registry.

Displaying 1417 - 1424 of 2710

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.